Loading...
XSHE002584
Market cap629mUSD
Jan 10, Last price  
7.89CNY
1D
1.15%
1Q
15.86%
IPO
46.73%
Name

Xilong Scientific Co Ltd

Chart & Performance

D1W1MN
XSHE:002584 chart
P/E
138.46
P/S
0.60
EPS
0.06
Div Yield, %
0.25%
Shrs. gr., 5y
-1.13%
Rev. gr., 5y
18.05%
Revenues
7.69b
+24.42%
766,705,162881,978,0261,164,155,3331,281,031,3961,544,721,1532,239,893,3542,197,935,7862,513,529,3162,928,383,5083,394,989,8183,355,078,3563,337,661,9616,243,170,9336,837,667,6336,183,208,8127,693,246,557
Net income
33m
-62.56%
46,703,43057,278,75872,894,39782,278,61964,301,62948,607,49377,528,16890,793,42196,789,60392,265,26170,577,60738,527,21458,187,577187,064,48689,063,74533,347,824
CFO
-285m
35,245,67049,543,76640,155,818013,554,37732,283,126104,508,649128,791,42711,002,0350095,892,72944,571,222346,617,6470-284,714,593
Dividend
Jul 10, 20240.02 CNY/sh

Profile

Xilong Scientific Co., Ltd. researches and develops, manufactures, and sells chemical reagents in China. The company offers chemical reagents, PCB reagents, high purity reagents, food additives, active pharmaceutical and chemical materials, and lab glassware products. It also exports its products. The company was formerly known as Xilong Chemical Co., Ltd. and changed its name to Xilong Scientific Co., Ltd. in December 2015. Xilong Scientific Co., Ltd. was founded in 1983 and is based in Shantou, China.
URL
http://www.xilongs.com/
IPO date
Jun 02, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
7,693,247
24.42%
6,183,209
-9.57%
Cost of revenue
7,401,729
5,963,057
Unusual Expense (Income)
NOPBT
291,517
220,152
NOPBT Margin
3.79%
3.56%
Operating Taxes
8,333
16,061
Tax Rate
2.86%
7.30%
NOPAT
283,184
204,091
Net income
33,348
-62.56%
89,064
-52.39%
Dividends
(11,704)
Dividend yield
0.22%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
726,170
818,271
Long-term debt
295,581
248,694
Deferred revenue
12,866
13,720
Other long-term liabilities
35,611
70,132
Net debt
89,280
7,547
Cash flow
Cash from operating activities
(284,715)
CAPEX
(215,248)
Cash from investing activities
139,530
Cash from financing activities
(30,124)
334,533
FCF
(153,089)
(206,962)
Balance
Cash
559,890
990,663
Long term investments
372,582
68,755
Excess cash
547,809
750,258
Stockholders' equity
1,507,133
1,633,963
Invested Capital
2,870,425
2,657,712
ROIC
10.25%
8.05%
ROCE
8.51%
6.45%
EV
Common stock shares outstanding
555,797
585,216
Price
9.79
41.27%
6.93
-34.62%
Market cap
5,441,253
34.17%
4,055,550
-34.62%
EV
5,536,595
4,068,905
EBITDA
340,817
264,615
EV/EBITDA
16.25
15.38
Interest
75,890
49,078
Interest/NOPBT
26.03%
22.29%